Figure 1.
Enhanced therapy after adjuvant therapy of TNBC. TNBC, triple negative breast cancer; BRCA, breast cancer susceptibility gene; PARPi, poly-ADP-ribose polymerase inhibitor.
Enhanced therapy after adjuvant therapy of TNBC. TNBC, triple negative breast cancer; BRCA, breast cancer susceptibility gene; PARPi, poly-ADP-ribose polymerase inhibitor.